CARLSBAD, Calif.--(BUSINESS WIRE)--Invitrogen Corporation (Nasdaq:IVGN) today announced results for its first quarter ended March 31, 2008. Revenues for the first quarter were $350 million, an increase of 13.5 percent over the $309 million reported for the first quarter of 2007.
